TelangiectasisNCT00206921
Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin Redness
A study testing Pulsed dye laser and Intense pulsed light in people with Telangiectasis and Erythema, run by Bispebjerg Hospital at 1 site in Denmark.
Trial summary
The purpose of the study is to compare efficacy and adverse effects of pulsed dye laser and intense pulsed light in patients with skin telangiectasia and redness. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Telangiectasis, Erythema
- What is being tested?
- Pulsed dye laser and Intense pulsed light
- Type of treatment
- Medical device
- How many people
- Not given
- Where
- 1 siteDenmark
- Study dates
- Feb 2005to Aug 2005
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Who may be able to join
- 18 years or older
- Skin types I, II, III
- No previous laser or IPL treatment for the condition
Who cannot join
- Younger than 18 years old
- Skin types IV, V, or VI
- Pregnant or lactating women
- Previous laser or IPL treatment for the condition
- Recent exposure to sun or sun-beds
- Treatment with oral retinoid within 6 months
- Tendency to produce hypertrophic scars or keloids
Trial locations and contacts
1 site in 1 country.
Denmark1 site, 1 recruiting
- Recruiting
Bispebjerg Hospital
Copenhagen, Copenhagen NV, 2400
Merete Hædersdal, MD, PhD, DrMedSci, +4535316002, mhaedersdal@dadlnet.dk
About this study
Official title: Pulsed Dye Laser and Intense Pulsed Light for the Treatment of Telangiectasia and Skin Redness
The purpose of the study is to compare efficacy and adverse effects of pulsed dye laser and intense pulsed light in patients with skin telangiectasia and redness.
- Conditions
- Telangiectasis, Erythema
- Being tested
- Pulsed dye laser, Intense pulsed light
- Keywords
- Telangiectasia, Skin redness
- Medical subject headings
- Telangiectasis, Erythema
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Pulsed dye laserDevice
Intense pulsed lightDevice
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Sep 2005 (estimated)
- Study startFeb 2005
- Study completionAug 2005
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for TelangiectasisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Single blind
Sponsor and investigators
- Lead sponsor
- Bispebjerg Hospital
- Sponsor type
- University, hospital or other
- Investigators
- Merete Hædersdal, MD, PhD, DrMedSci, Principal investigator, Bispebjerg Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00206921
- Sponsor's protocol ID
- KF-01-236/04
- Status last verified
- Dec 2004
- First submitted
- 13 Sep 2005
- Last updated
- 25 Jul 2007
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Jul 2007. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Pulsed Dye Laser and Intense Pulsed Light for the Treatment of Telangiectasia and Skin Redness
- ClinicalTrials.gov ID
- NCT00206921
- Acronym / sponsor ID
- KF-01-236/04
- Conditions
- Telangiectasis, Erythema
- Keywords
- Telangiectasia, Skin redness
- Study type
- Interventional
- Recruitment status
- Unknown status
- Lead sponsor
- Bispebjerg HospitalUniversity, hospital or other
- Study start
- Feb 2005
- Study completion
- Aug 2005
- First posted
- 21 Sep 2005 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of the study is to compare efficacy and adverse effects of pulsed dye laser and intense pulsed light in patients with skin telangiectasia and redness.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Single blind
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- 18 years or older
- Skin types I, II, III
- No previous laser or IPL treatment for the condition
Key exclusion criteria (7 listed)
- Younger than 18 years old
- Skin types IV, V, or VI
- Pregnant or lactating women
- Previous laser or IPL treatment for the condition
- Recent exposure to sun or sun-beds
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Pulsed dye laser | Device | – |
| Intense pulsed light | Device | – |
Primary outcome
Not reported in the source record.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Jul 2007.
Related trials for Telangiectasis
Not yet recruitingPhase 1
Topical TOR-582 Treatment of Epistaxis in HHT
Hereditary Hemorrhagic Telangiectasia (HHT), Epistaxis
RecruitingPhase 4
Foam Sclerotherapy With or Without Transdermal Laser for Reticular Veins and Telangiectasias
Telangiectasias, Reticular Veins
RecruitingPhase 1/2
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
Hereditary Hemorrhagic Telangiectasia (HHT), Osler Weber Rendu Disease
RecruitingPhase 3
A Study to Determine the Safety and Efficacy of NT-501 With M-CHFM
Macular Telangiectasia Type 2
Active, not recruitingPhase 3
A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)
Ataxia-Telangiectasia, Ataxia-Telangiectasia (A-T)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Merete Hædersdal, MD, PhD, DrMedSci principal investigator
Bispebjerg Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Pulsed dye laser and Intense pulsed light in people with Telangiectasis and Erythema, run by Bispebjerg Hospital at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 25 Jul 2007. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Merete Hædersdal, MD, PhD, DrMedSci (+45 35 31 60 02, mhaedersdal@dadlnet.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jul 2007.